NICOLE PETERSON: Open Payments
NPI 1710756069 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 55 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $690 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $141 |
| Lilly USA, LLC | 5 | $103 |
| Vifor Pharma, Inc. | 5 | $102 |
| Mallinckrodt Hospital Products Inc. | 3 | $74 |
| SCPHARMACEUTICALS INC. | 3 | $66 |
| Travere Therapeutics, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Fresenius USA Marketing, Inc. | 3 | $55 |
| Ardelyx, Inc. | 2 | $47 |
Products named: TARPEYO, Kerendia, JARDIANCE, Veltassa, FUROSCIX, VELPHORO, ACTHAR, IBSRELA.
Industry payments across NE — which companies pay providers there.
